Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4356-4362

  Molina, Miguel A ^a   Sitja Arnau, Marta ^a   Lemoine, Michael G ^a   Frazier, Marsha L ^a   Sinicrope, Frank A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; RNA; SULINDAC SULFIDE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PANCREATIC NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SULFONAMIDES; SULINDAC; TUMOR CELLS, CULTURED;

EID: 0033199017     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Landis, S. H., Murray, T., Holden, S., and Wingo, P. A. Cancer Statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Brand, R. E., and Tempere, M. A. Pancreatic cancer. Curr. Opin. Oncol., 10: 362-366, 1998.
3. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and-2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
4. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. M. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
5. Williams, C. S., Luongo, C., Radhika, A., Chang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
6. Kawamori, T., Rao, C. V., Seibet, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
7. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 87: 803-809, 1996.
8. Gupta, R. A., and DuBois, R. N. Aspirin, NSAIDs, and colon cancer prevention. Mechanism? Gastroenterology, 114: 1095-1098, 1998.
9. Sinicrope, F. A., Lemoine, M., Xi, L., Lynch, P. M., Cleary, K. R., Shen, Y., and Frazier, M. L. Reduced expression of cyclooxygenase-2 proteins in hereditary non-polyposis colorectal cancers relative to sporadic cancers. Gastroenterology, 117: 350-358, 1999.
10. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
11. Wilson, K. T., Fu, S., Ramanujam, K. S., and Meltzer, S. J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res., 58: 2929-2934, 1998.
12. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59: 198-204, 1999.
13. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
14. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
15. Smith, W. L., Garavito, M., and DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem., 271: 33157-33160, 1996.
16. Eberhart, C. E., and DuBois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
17. Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., and Dannenberg, A. J. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res., 57: 2890-2895, 1997.
18. Sato, T., Nakajima, H., Fujio, K., and Mori, Y. Enhancement of prostaglandin E2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase-2 in human squamous carcinoma A431 cells. Prostaglandins, 53: 355-369, 1997.
19. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
20. Thun, J. M., Namboodiri, M. M., and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596. 1991.
21. Takahashi, M., Furukawa, F., Toyoda, K., Sato, H., Hasegawa, R., Imaida, K., and Hayashi, Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis (Lond.), 11: 393-395, 1990.
22. Piazza, G. A., Rahm, A. L. K., Krutzsch. M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D S., Pamukcu, R., and Ahnen, D. J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 53: 3110-3116, 1995.
23. Shiff, S. J., Qiao, L., Tsai, L. L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96: 491-503, 1995.
24. Sheng. H., Shao, L. Kirkland, S C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99: 2254-2259, 1997.
25. Elder, D. J. E., Halton, D. E., Hague, A., and Paraskeva, C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res., 3: 1679-1683, 1997.
26. Liu, X-H., Yao, S., Kirschenbaum, A., and Levine, A. C. NS398, a selective cyclooxygenase inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58: 4245-4249, 1988.
27. Piazza, G. A., Alberts, D. S., Hixson, L. J., Paranka, N. S., Li, H., Finn, T., Bogert, C., Guillen, J. M., Brendel, K., Gross, P. H., Sperl, G., Ritchie, J., Burt, R. W., Ellsworth, L., Ahnen, D. J., and Pamukcu, R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57: 2909-2915, 1997.
28. Lanza, F. L., Rack, M. F., Callison, D. A., Hubbard, R. C., Yu, S. S., Talwalker, S., and Geis, G. S. A. A pilot endoscopic study of the gastroduodenal effects of SC-58635, a novel COX-2 selective inhibitor. Gastroenterology. 112: A194, 1997.
29. Fogh, G., Wright, W. C., and Loveless, J. O. Absence of HeLa contaminants in 169 cell lines derived from human tumors. J. Natl. Cancer Inst., 58: 209-214, 1977.
30. Frazier, M. L., Pathak, S., Wang, Z-W., Cleary, K., Singletary, S. E., Olive, M., Mackay, B., Steck, P., and Levin, B. Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3. Pancreas, 5: 8-16, 1990.
31. Tan, M. H., Nowak, N. J., Loor, R., Ochi, H., Sandberg, A. A., Lopez, C., Pickren, J. W., Berjian, R., Douglass, H. O., and Chu, M. T. Characterization of a new primary human pancreatic tumor line. Cancer Invest., 4: 15-23, 1986.
32. Frazier, M. L., Fernandez, E., de Llorens, R., Brown, N., Pathak, S., Cleary, K., Abbruzzese, J. L., Berry, K., Olive, M., Le Maistre, A., and Evans, D. B. Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. Int. J. Pancreatol., 19: 31-38, 1996.
33. Lieber, M., Mazzetta, J., Nelson-Rees, W., Kaplan, M., and Todaro, G. Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas. Int. J. Cancer, 15: 741-747, 1975.
34. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
35. Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T., and Hla, T. Induction of cyclooxygenase-2 by interleukin-1 α. Evidence for post-transcriptional regulation. J. Biol. Chem., 269: 11769-11775, 1994.
36. Robertson, R. P. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes, 47: 1379-1383, 1998.
37. O'Neill, G. P., and Ford-Hutchinson, A. W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330: 156-160, 1993.
38. Smith, J. J., Derynck, R., and Korc, M. Production of transforming growth factor a in human pancreatic cells: evidence for a superagonist autocrine cycle. Proc. Natl. Acad. Sci. USA, 84: 7567-7570, 1987.
39. Piazza, G. A., Rahm, A. L. K., Finn, T. S., Fryer, B. H., Li, H., Stoumen, A. L., Pamukcu, R., and Ahnen, D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res., 57: 2452-2459, 1997.
40. Herrmann, C., Block, C., Geisen, C., Haas, K., Weber, C., Winde, G., Moroy, T., and Muller, O. Sulindac sulfide inhibits Ras signaling. Oncogene, 17: 1769-1776, 1998.
41. Aoki, K., Yoshida, T., Matsumoto, N., Ide, H., Sugimura, T., and Terada, M. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation. Mol. Carcinog., 20: 251-258, 1997.
42. Meade, E. A., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem., 274: 8328-8334, 1999.
43. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.